Vision and Mission
Our goal is to complete the development and bring to market potential medications/procedures that address a significant number of the most highly visible health issues currently afflicting mankind—Amyotrophic Lateral Sclerosis (ALS/Lou Gehrig’s Disease), Traumatic Brain Injury (TBI), Multiple Sclerosis (MS), Blood Sepsis, and Cancer. Premier Biomedical, Inc. is in the process of developing targeted medicines and procedures and will prove out their superior efficacy in addressing these diseases and others through laboratory, hospital, and actual patient applications. At the anticipated successful conclusion of the clinical trials, contact will be established with the leading worldwide pharmaceutical firms via publication in medical journals and by direct contact to establish their potential right to market and distribute Premier Biomedical, Inc. technology products and procedures. If successful, Premier Biomedical, Inc. will remain an advanced research and development (R&D) arm of the world’s large pharmaceutical firms.